BIRC2 and hepatocellular carcinoma: The overexpression of Bcl-2 and IAP-2 has been identified in a variety of human cancers (50,51) and it has been reported that miR-29s target Bcl-2 in both hepatocellular carcinoma (HCC) and OS cell line (52,24).